Product Images Crixivan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Crixivan NDC 21695-366 by Rebel Distributors Corp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structural formula - 01c5574c 1056 49c6 af20 e950db3f4139 01
indinavir protocol figure 1 - 01c5574c 1056 49c6 af20 e950db3f4139 02
This appears to be a chart or graph displaying the proportion of patients on different treatment regimens (IDV+ZDV+L or ZDV+L) over a study period of 40 weeks. The numbers in the chart may represent the number of patients on each treatment at each time point. However, without further context or a clearer image, it is difficult to provide more specific information.*
CD4 cell counts Figure 2 - Study ACTG 320 - 01c5574c 1056 49c6 af20 e950db3f4139 03
This appears to be a table comparing the effectiveness of two different combinations of medications for HIV treatment. The first combination includes Indinavir, Zidovudine, and Lamivudine, while the second combination only includes Zidovudine and Lamivudine. The table displays results by study week and IDV+ZDV+L had higher numbers for each week.*
indinavir protocol 028 figure 3 - 01c5574c 1056 49c6 af20 e950db3f4139 04
This is a chart showing the proportion of patients on different treatment regimens (1DV + ZDV, Indinavir + Zidovudine, and Indinavir alone or Zidovudine alone) over a 48-week study period. The chart also includes the number of patients (N) at each study week for each regimen.*
indinavir protocol 028 figure 4 - 01c5574c 1056 49c6 af20 e950db3f4139 05
This appears to be a table with no clear meaning as there are no column or row headings. It is likely a dataset from a scientific study analyzing the effects of a combination of Indinavir and Zidovudine on patients. Without additional information or context, it is not possible to provide a detailed description.*
indinavir protocol 035 figure 5 - 01c5574c 1056 49c6 af20 e950db3f4139 06
This appears to be a table showing the RNA change (Log10 copies/mL) for different drug combinations of Indinavir, Zidovudine, and Lamivudine at different study weeks. There are three different drug combinations tested (Indinavir+Zidovudine+Lamivudine, Indinavir, and Zidovudine+Lamivudine), with 30-33 participants in each group. The study lasted for 24 weeks.*
indinavir protocol 035 figure 6 - 01c5574c 1056 49c6 af20 e950db3f4139 07
indinavir protocol 035 figure 7 - 01c5574c 1056 49c6 af20 e950db3f4139 08
This document appears to be a chart or table presenting data regarding three different treatments. The treatments are Indinavir + Zidovudine + Lamivudine, Indinavir, and Zidovudine + Lamivudine. The top row appears to show a dosage in grams. The left-hand column shows a cell count change, and the rows below it contain numbers that seem to correspond with individual weeks of the study. There are also ID numbers for each treatment. In some cases, the box is populated with a number, while in others, it only contains an "N". Without more context, it is difficult to draw any further conclusions from this data.*
Crixivan 400mg - 01c5574c 1056 49c6 af20 e950db3f4139 09
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.